Maruti Futuristic Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
as on 16-12-2024
- Paid Up Capital ₹ 0.20 M
as on 16-12-2024
- Company Age 15 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 4.50 M
as on 16-12-2024
- Revenue -14.27%
(FY 2022)
- Profit 43.84%
(FY 2022)
- Ebitda 32.67%
(FY 2022)
- Net Worth 2456.53%
(FY 2022)
- Total Assets 66.90%
(FY 2022)
About Maruti Futuristic Pharma
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.20 M.
The company has closed loans amounting to ₹4.50 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Tankasala Mayur, Devi Gurram, Shreyaa Tankasala, and One other member serve as directors at the Company.
- CIN/LLPIN
U74900KA2009PTC051149
- Company No.
051149
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Oct 2009
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Maruti Futuristic Pharma Private Limited offer?
Maruti Futuristic Pharma Private Limited offers a wide range of products and services, including Common Disease Medicines, Hair Growth Medicine, Pharma Ingredients & Raw Materials, Blood System and Cardiovascular API, Pharmaceutical Tablets, API (Active Pharmaceutical Ingredients).
Who are the key members and board of directors at Maruti Futuristic Pharma?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Tankasala Mayur  | Director | 09-Oct-2009 | Current |
| Devi Gurram | Director | 30-Sep-2021 | Current |
| Shreyaa Tankasala | Director | 20-Oct-2009 | Current |
| Deepashree | Director | 30-Sep-2021 | Current |
Financial Performance of Maruti Futuristic Pharma.
Maruti Futuristic Pharma Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 14.27% decrease. The company also saw a substantial improvement in profitability, with a 43.84% increase in profit. The company's net worth Soared by an impressive increase of 2456.53%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Maruti Futuristic Pharma?
In 2022, Maruti Futuristic Pharma had a public holding of 50.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Yes Bank Limited Creation Date: 27 Mar 2019 | ₹4.50 M | Satisfied |
How Many Employees Work at Maruti Futuristic Pharma?
Unlock and access historical data on people associated with Maruti Futuristic Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Maruti Futuristic Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Maruti Futuristic Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
